Tumour evolution inferred by single-cell sequencing-Reference-Cited by-同舟云学术

Tumour evolution inferred by single-cell sequencing

Published:2011-03-13 Issue:7341 Volume:472 Page:90-94
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Navin Nicholas,Kendall Jude,Troge Jennifer,Andrews Peter,Rodgers Linda,McIndoo Jeanne,Cook Kerry,Stepansky Asya,Levy Dan,Esposito Diane,Muthuswamy Lakshmi,Krasnitz Alex,McCombie W. Richard,Hicks James,Wigler Michael

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/nature09807.pdf

Reference25 articles.

1. Park, S. Y., Gonen, M., Kim, H. J., Michor, F. & Polyak, K. Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J. Clin. Invest. 120, 636–644 (2010)

2. Torres, L. et al. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases. Breast Cancer Res. Treat. 102, 143–155 (2007)

3. Farabegoli, F. et al. Clone heterogeneity in diploid and aneuploid breast carcinomas as detected by FISH. Cytometry 46, 50–56 (2001)

4. Chiang, D. Y. et al. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nature Methods 6, 99–103 (2009)

5. Yoon, S., Xuan, Z., Makarov, V., Ye, K. & Sebat, J. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Res. 19, 1586–1592 (2009)

Cited by 2207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From single cell to spatial multi-omics: unveiling molecular mechanisms in dynamic and heterogeneous systems;Current Opinion in Biotechnology;2024-10

2. The evolutionary theory of cancer: challenges and potential solutions;Nature Reviews Cancer;2024-09-10

3. Inferring Characteristics of the Tumor Immune Microenvironment of Patients with HNSCC from Single-Cell Transcriptomics of Peripheral Blood;Cancer Research Communications;2024-09-01

4. Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs;Cancer Letters;2024-09

5. Leveraging preclinical models of metastatic breast cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09